Meir Medical Center
Kfar Saba, Israel
NCT Number: NCT06929494
Candidal sepsis (candidemia) is a criticals problem in patients hospitalized in the intensive care unit, with a significant impact on morbidity and mortality. Risk factors for candidemia in intensive care patients included age, presence of a central venous catheter, inpatient surgery, and administration of parenteral nutrition (TPN). Mortality in patients with candidemia is estimated at 50-60%. Early identification and treatment, including control of the source of infection, are essential to improve morbidity and mortality in these patients.
In this study, we would like to identify risk factors for the development of candidemia in intensive care patients, including those who have not undergone abdominal surgery, and to examine what percentage of patients who developed candidemia were given empirical antifungal therapy and what factors influenced the decision to give or not to give such empirical therapy.
Study design: A retrospective study based on data collection from computerized systems will include patients who were hospitalized in the intensive care unit from January 2014 to December 2024 and were diagnosed with Candida in at least one blood culture.
Trial opening soon.
Get Notified18 year–99 year
All sexes
Observational
Kfar Saba, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients admitted to the ICU from January 2014 to December 2024 and had at least one positive blood culture for candidemia -
Exclusion criteria
Missing data
-
Identification of risk factors for candidemia
Time frame: Throughout ICU stay (from admission to 28 days post ICU discharge)
Identification of risk factors for candidemia
Meir Medical Center
Other
Candidemia in Critically Ill Patients: Risk Factors and Predictive Factors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739004
Body Temperature Changes, Disease Attributes
Kayseri, Talas, Turkey (Türkiye)
View Trial DetailsNCT07739251
Infections, Inflammation
View Trial DetailsNCT07670624
Biomarker Discovery, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Wroclaw, Poland
View Trial DetailsNCT07735741
Infections, Inflammation
Falls Church, Virginia, United States
View Trial Details